Caplight Directory>Companies>CaLycia Bioscience-preview>Calyciabioscience


CaLycia Bioscience

CaLycia Bioscience

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.calyciabioscience.com/

Last Round

VC Round

Jan 15, 2026

Company Overview

CaLycia Bioscience is a biotechnology company developing novel myeloid-based cell therapies designed to treat solid tumors like glioblastoma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

engineered macrophagesmyeloid cell therapysolid tumor therapyglioblastomacell therapyimmunotherapyliving drugoncologytumor microenvironmentpreclinical biotechstealth biotechuniversity spin-outdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CaLycia Bioscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CaLycia Bioscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 15, 2026
View all Funding Rounds

CaLycia Bioscience Investors

Notable investors and investment history

InvestorRounds
Cumming Capital ManagementVC Round
EPIC VenturesVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 15, 2026

    Led by Cumming Capital Management and University of Utah

View all signals

CaLycia Bioscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CaLycia Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CaLycia Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Year Founded2025
Last FundingJan 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.